Dolby Laboratories (NYSE:DLB) CEO Sells $1,721,750.00 in Stock

Dolby Laboratories (NYSE:DLB) CEO Kevin Yeaman sold 25,000 shares of the stock in a transaction on Tuesday, October 14th. The stock was sold at an average price of $68.87, for a total value of $1,721,750.00. Following the transaction, the chief executive officer owned 114,725 shares of the company’s stock, valued at $7,901,110.75. This represents a 17.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Dolby Laboratories Stock Performance

DLB opened at $68.79 on Friday. The firm has a market cap of $6.59 billion, a price-to-earnings ratio of 25.20 and a beta of 0.92. The firm’s 50-day simple moving average is $71.85 and its 200-day simple moving average is $73.66. Dolby Laboratories has a twelve month low of $67.54 and a twelve month high of $89.66.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings results on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, beating analysts’ consensus estimates of $0.72 by $0.06. The firm had revenue of $315.55 million for the quarter, compared to analyst estimates of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.71 earnings per share. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, sell-side analysts anticipate that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Dolby Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were paid a $0.33 dividend. The ex-dividend date of this dividend was Tuesday, August 12th. This represents a $1.32 dividend on an annualized basis and a yield of 1.9%. Dolby Laboratories’s payout ratio is currently 48.35%.

Hedge Funds Weigh In On Dolby Laboratories

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. CWM LLC raised its position in shares of Dolby Laboratories by 31.8% during the 3rd quarter. CWM LLC now owns 28,678 shares of the electronics maker’s stock valued at $2,075,000 after acquiring an additional 6,926 shares during the last quarter. Pacer Advisors Inc. grew its stake in shares of Dolby Laboratories by 98.2% during the third quarter. Pacer Advisors Inc. now owns 443,897 shares of the electronics maker’s stock worth $32,125,000 after purchasing an additional 219,901 shares during the period. Voya Investment Management LLC grew its stake in shares of Dolby Laboratories by 100.9% during the third quarter. Voya Investment Management LLC now owns 13,567 shares of the electronics maker’s stock worth $982,000 after purchasing an additional 6,813 shares during the period. Mitchell & Pahl Private Wealth LLC increased its holdings in Dolby Laboratories by 1.1% in the third quarter. Mitchell & Pahl Private Wealth LLC now owns 15,733 shares of the electronics maker’s stock valued at $1,139,000 after purchasing an additional 170 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in Dolby Laboratories by 18.6% in the third quarter. Assenagon Asset Management S.A. now owns 41,688 shares of the electronics maker’s stock valued at $3,017,000 after buying an additional 6,542 shares during the period. 58.56% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on DLB. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, August 30th. Barrington Research reaffirmed an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research note on Friday, September 12th. Baird R W raised shares of Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Tigress Financial raised their price target on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a report on Friday, August 15th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Dolby Laboratories in a report on Wednesday, October 8th. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $95.75.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.